Botulinum toxin therapy for cervical dystonia

Neurotoxicity Research

Volumn 9, Issue 2-3, 2006, Pages 145-148

  Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Botulinum toxin; Cervical; Dystonia

Indexed keywords

BOTULINUM TOXIN; MUSCLE RELAXANT AGENT;

HUMAN; IMMUNOLOGY; MUSCLE DENERVATION; REVIEW; TORTICOLLIS;

BOTULINUM TOXINS; HUMANS; MUSCLE DENERVATION; NEUROMUSCULAR AGENTS; TORTICOLLIS;

EID: 33747161909     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033933     Document Type: Article

References (24)

1. Benecke R, WH Jost, P Kanovsky, E Ruzicka, G Comes and S Grafe (2005) A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology 64, 1949-1951.
2. Berman B, L Seeberger and R Kumar (2005) Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia. Mov. Disord. 20, 233-237.
3. Comella CL, J Jankovic, S Daggett, J Mordaunt and MF Brin (2004) Interim results of an observational study of neutralizing antibody formation with the current preparation of botulinum toxin type A treatment for cervical dystonia. Neurology 62(Suppl. 5), A511.
4. Comella CL, J Jankovic, KM Shannon, J Tsui, M Swenson, S Leurgans and W Fan Dystonia Study Group (2005) Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology 65, 1423-1429.
5. Consky ES and AE Lang (1994) Clinical assessments of patients with cervical dystonia, In: Therapy with Botulinum Toxin (Jankovic J and M Hallett, Eds.) (Marcel Dekker: New York, NY), pp 211-237.
6. Diamond A, J Shahed, S Azher, K Dat-Vuong, R Simpson and J Jankovic (2005) Globus pallidus deep brain stimulation in dystonia. Mov. Disord. 2005 Dec 9; [Epub ahead of print].
7. Dressler D and R Benecke (2003) Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur. Neurol. 49, 34-38.
8. Dressler D and H Bigalke (2005) Botulinum toxin type B de novo therapy of cervical dystonia: Frequency of antibody induced therapy failure. J. Neurol. 252, 904-907.
9. Dressler D, M Lange and H Bigalke (2005) Mouse diaphragm assay for detection of antibodies against botulinum toxin type B. Mov. Disord. 20, 1617-1619.
10. Ertekin C, I Aydogdu, Y Secil, N Kiylioglu, S Tarlaci and T Ozdemirkiran (2002) Oropharyngeal swallowing in craniocervi-cal dystonia. J. Neurol. Neurosurg. Psychiatry 73, 406-411.
11. Factor SA, ES Molho, S Evans and PJ Feustel (2005) Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia. Mov. Disord. 20, 1152-1160.
12. Jankovic J (2004a) Treatment of cervical dystonia with botulinum toxin. Mov. Disord. 19(Suppl. 8), S109A-S115A.
13. Jankovic J (2004b) Botulinum toxin in clinical practice. J. Neurol. Neurosurg. Psychiatry 75, 951b-957b.
14. Jankovic J, KD Vuong and J Ahsan (2003) Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 60, 1186-1188.
15. Jankovic J, A Esquenazi, D Fehling, F Freitag, AM Lang and M Naumann (2004) Evidence-based review of patient reported outcomes with botulinum toxin type A. Clin. Neuropharmacol. 27, 234-244.
16. Jankovic J, J Tsui and C Bergeron (2005a) Prevalence of cervical dystonia and spasmodic torticollis in the United States. Mov. Disord. 20(Suppl. 10) S22a.
17. Jankovic J, CB Hunter and the BOS Study Group (2005b) Botulinum toxin type B observational study. Ann. Neurol. 58(Suppl. 9) S54.
18. Marchetti A, R Magar, L Findley, JP Larsen, Z Pirtosek, E Ruzicka, R Jech, J Slawek and F Ahmed (2005) Retrospective evaluation of the dose of Dysport® and BOTOX® in the management of cervical dystonia and blepharospasm: The REAL DOSE study. Mov. Disord. 20, 937-944.
19. Mejia NI, KD Vuong and J Jankovic (2005) Long-term botulinum toxin efficacy, safety and immunogenicity. Mov. Disord. 20, 592-597.
20. Naumann M and J Jankovic (2004) Safety of botulinum toxin type A: A systematic review and meta-analysis. Curr. Med. Res. Opin. 20, 981-990.
21. Riski JE, J Horner and BS Nashold Jr (1990) Swallowing function in patients with spasmodic torticollis. Neurology 40, 1443-1445.
22. Tintner R, R Gross, UF Winzer, KA Smalky and J Jankovic (2005) Autonomic function after botulinum toxin type A or B: A double-blind, randomized trial. Neurology 65, 765-767.
23. Truong D, DD Duane, J Jankovic, C Singer, LC Seeberger, CL Comella, MF Lew, RL Rodnitzky, FO Danisi, JP Sutton, PD Charles, RA Hauser and GL Sheean (2005) Efficacy and safety of botulinum type A toxin (Dysport®) in cervical dystonia: Results of the first US randomized, double-blind, placebo-controlled study. Mov. Disord. 20, 783-791.
24. Vidailhet M, L Vercueil, JL Houeto, P Krystkowiak, AL Benabid, P Cornu, C Lagrange, S Tezenas du Montcel, D Dormont, S Grand, S Blond, O Detante, B Pillon, C Ardouin, Y Agid, A Destee, P Pollak and the French Stimulation du Pallidum Interne dans la Dystonie (SPIDY) Study Group (2005) Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N. Engl. J. Med. 352, 459-467.